COMMUNIQUÉS West-GlobeNewswire

Cannabix Technologies Files Provisional Patent Application for BCU-Enabled Point-of-Care Marijuana Breath Testing
14/10/2026
VANCOUVER, British Columbia, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”), a developer of marijuana and alcohol breath testing [...]
SeaStar Medical Chief Medical Officer Kevin Chung, MD, Named 2026 Recipient of the Combat Nephrology Award
14/10/2026
Award recognizes Dr. Chung’s extraordinary career as an internationally known expert in burn critical care, combat casualty care, acute organ failure, and extracorporeal organ support Keynote presentation and award [...]
Family Medicine Forum, Canada’s largest family medicine celebration, returns to Toronto this November
14/10/2026
Celebrating family medicine with four days of learning, networking, and events MISSISSAUGA, Ontario, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Family Medicine Forum (FMF) is back in Toronto, November 11th to 14th, for four days [...]
Le Forum en médecine familiale, le plus grand rassemblement de médecins de famille au Canada, revient à Toronto en novembre!
14/10/2026
Célébrez la médecine de famille avec quatre jours d’apprentissage, de réseautage et d’événements MISSISSAUGA, Ontario, 14 oct. 2026 (GLOBE NEWSWIRE) -- Le Forum en médecine familiale (FMF) est de retour à Toronto, du 11 [...]
Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $203 Million
14/10/2026
Agreement marks the Company’s second PRV sale within one week, following the previously announced GENGLYCOS™ PRV transaction NOVATO, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE [...]
Propanc Biopharma Announces Publication of Pilot Study Demonstrating Potent Anti-Tumor Efficacy of PRP Pancreatic Proenzyme Formulation in Pancreatic & Ovarian Cancer
14/10/2026
Scientific Reports Paper Shows Synergistic Trypsinogen/Chymotrypsinogen A Combination (1:6) Inhibits Angiogenesis, Migration, Invasion and EMT While Delivering Significant Tumor Reduction in Orthotopic Models and [...]
Prodeon Medical Announces First Commercial Case of the Urocross® Expander System
14/10/2026
First procedure at The Hospital at Westlake Medical Center in Austin, Texas, marks the beginning of the company’s controlled U.S. commercial release SAN JOSE, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Prodeon Medical , [...]
SAB BIO to Participate in Chardan 10th Annual Healthcare Conference
14/10/2026
MIAMI, Oct. 14, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and [...]
Rad Source Launches AccuTag™ Blood Irradiation Indicators Ahead of AABB 2026
14/10/2026
White-to-blue indicator gives blood banks visual confirmation of the 15 Gy minimum at a 25 Gy target dose, on display at Booth 1314 BUFORD, Ga., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Rad Source Technologies, Inc. (Rad [...]
Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and Advances Huntington's Disease Franchise
14/10/2026
- Proprietary siRNA platforms, designed to enable robust and durable gene silencing throughout the brain, support a differentiated Huntington’s disease franchise and broader neurological disease pipeline focused on [...]
Elion Therapeutics Expands Pipeline with Exclusive Global License to Inhaled Antifungal for Immunocompromised Patients
14/10/2026
- Phase 2-Ready EL777 Complements Company’s Turletricin Program Focused on Early Antifungal Treatment - Prophylaxis Is Critical for Cancer and Transplant Patients at High Risk of Invasive Fungal Infections BOSTON, Oct. [...]
Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis
14/10/2026
New dose-ranging cohort in FAP builds on compelling early clinical evidence observed with zolucatetide in patients with FAP and concomitant desmoid tumors Zolucatetide directly inhibits β-catenin:TCF, targeting the APC- [...]
Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026
14/10/2026
ALACHUA, Fla. and TAMPA, Fla., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, [...]
Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film
14/10/2026
Differentiated, portable buccal film would offer patients and caregivers an alternative to existing nasal and rectal seizure rescue treatments, a market opportunity that exceeds $450 million annually in the U.S. Patient [...]
Ocugen and Roots Pharmaceutical Complete License Agreement for OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa
14/10/2026
Establishes strategic commercial reach across the Middle East and North Africa, advancing Ocugen’s goal of enabling global patient access to potentially transformational gene therapies Expands access to a potential one- [...]
Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome
14/10/2026
– Company on track to initiate first-ever formal clinical trial in Peeling Skin Syndrome before year end – Orphan Drug designation milestone provides 10 years of market exclusivity for Peeling Skin Syndrome in Europe [...]
Rakovina Therapeutics Secures Exclusivity on Optimized kt-5000 Lead Profile from Variational AI
14/10/2026
Agreement provides Rakovina exclusive access to its optimized kt-5000 target profile and extends AI-powered lead optimization through year-end at no additional cost VANCOUVER, British Columbia, Oct. 14, 2026 (GLOBE [...]
CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset
14/10/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 14, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) ("CDT" or the "Company") today notes the announcement from Sarborg Limited regarding intellectual property [...]
MaxCyte Reports Preliminary Third Quarter 2026 Revenue and Raises Full Year 2026 Revenue Guidance
14/10/2026
MaxCyte will host its third quarter 2026 earnings conference call on November 10, 2026 ROCKVILLE, Md., Oct. 14, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading cell-engineering company providing [...]

Pages